In both colon cancer cell lines (HT-29 and LoVo), downregulation of NAT10 impaired the proliferative, migratory, invasive, tumor-forming, and metastatic abilities of these cells; conversely, excess NAT10 expression promoted these abilities. The gene discussed is NAT10; the disease is colonic neoplasm.